妊娠期接种SARS-CoV-2疫苗后母婴抗体转移:一项前瞻性队列研究
该前瞻性队列研究纳入52名妊娠期接种至少一剂SARS-CoV-2疫苗的孕妇及其新生儿,检测分娩时和产后4-6周的IgG和IgA滴度。结果显示,无既往感染证据者中接种3剂及以上疫苗者抗S IgG几何平均浓度在脐血清、产后母血清、婴儿血清和母乳中均显著高于接种2剂者;有感染史者抗S IgG更高;母婴配对样本抗S IgG呈强正相关。
要点
- 接种3剂及以上疫苗者脐血清、产后母血清、婴儿血清和母乳抗S IgG均显著高于2剂者。
- 有SARS-CoV-2感染史的3剂及以上接种者抗S IgG显著高于无感染者。
- 分娩时和产后母婴配对样本抗S IgG呈显著正相关。
核心结论
- 妊娠期接种SARS-CoV-2疫苗和感染均可诱导强烈的IgG和IgA抗体反应,并有经胎盘转移至胎儿的证据。
研究设计与样本
- 前瞻性队列研究,纳入52名妊娠期接种至少一剂SARS-CoV-2疫苗的孕妇及其新生儿,在一家三级产科中心开展,检测分娩时和产后4-6周样本的IgG和IgA浓度并用Spearman相关分析比较。
主要发现
- 无既往感染证据者中,接种3剂及以上者分娩时母血清抗S IgG几何平均浓度(log10 AU/mL)为5.00,接种2剂者为4.60,p=0.08。
- 脐血清抗S IgG几何平均浓度3剂及以上组为5.32,2剂组为4.98,p<0.05。
- 产后母血清抗S IgG几何平均浓度3剂及以上组为5.25,2剂组为4.57,p<0.001。
- 产后婴儿血清抗S IgG几何平均浓度3剂及以上组为5.10,2剂组为4.72,p=0.03;产后母乳为2.61 vs 1.94,p<0.0001。
- 3剂及以上接种者中有感染史者抗S IgG几何平均浓度高于无感染者:分娩时母血清5.65 vs 5.00(p=0.004),脐血清5.68 vs 5.32(p=0.02),产后母血清5.66 vs 5.25(p<0.001),产后婴儿血清5.50 vs 5.10(p=0.003),产后母乳3.25 vs 2.61(p=0.009)。
关键数值与推荐
- 分娩时母血清抗S IgG几何平均浓度3剂及以上组5.00 vs 2剂组4.60,p=0.08,未达统计学显著。
- 脐血清抗S IgG几何平均浓度3剂及以上组5.32 vs 2剂组4.98,p<0.05。
- 产后母血清抗S IgG几何平均浓度3剂及以上组5.25 vs 2剂组4.57,p<0.001。
- 产后婴儿血清抗S IgG几何平均浓度3剂及以上组5.10 vs 2剂组4.72,p=0.03;产后母乳2.61 vs 1.94,p<0.0001。
- 分娩时和产后母婴配对样本抗S IgG正相关:分娩时R=0.91(p<0.001),产后R=0.86(p<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To measure and evaluate the impact of receiving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in pregnancy on immunoglobulin G (IgG) and immunoglobulin A (IgA) titres in maternal and infant samples. DESIGN: Prospective cohort study. SETTING: Tertiary obstetric centre. POPULATION OR SAMPLE: 52 pregnant women who received one or more SARS-CoV-2 vaccine doses during pregnancy and their neonates. METHODS: IgG and IgA concentrations against SARS-CoV-2 antigens were measured from samples collected at delivery and 4-6 weeks postpartum and compared using Spearman correlations. MAIN OUTCOME MEASURES: Maternal and infant IgG and IgA titres in response to vaccination and infection in pregnancy. RESULTS: In maternal serum collected at delivery, participants without evidence of prior infection who received 3 + doses of a SARS-CoV-2 vaccine had higher Anti-Spike (S) IgG geometric mean concentrations (log10 AU/mL)(GMC) than those who received 2 doses (3 + Doses = 5.00, 2 Doses = 4.60, p = 0.08). The differences in IgG Anti-S GMC were statistically significant in cord serum, and in postpartum samples of maternal serum, infant serum and breast milk (Cord GMCs: 3 + Doses = 5.32, 2 Doses = 4.98, p < 0.05; Postpartum maternal serum GMCs: 3 + Doses = 5.25, 2 Doses = 4.57, p < 0.001; Postpartum infant serum GMCs: 3 + Doses = 5.10, 2 Doses = 4.72, p = 0.03; Postpartum breast milk GMCs: 3 + Doses = 2.61, 2 Doses = 1.94, p < 0.0001). Among participants with 3 + Doses, those with evidence of SARS-CoV-2 infection had statistically significant higher anti-S IgG GMCs than those without prior infection (Maternal serum at delivery: SARS-CoV-2+=5.65, SARS-CoV-2-=5.00, p = 0.004; Cord: SARS-CoV-2+=5.68, SARS-CoV-2-=5.32, p = 0.02; Postpartum maternal serum: SARS-CoV-2+=5.66, SARS-CoV-2-=5.25, p < 0.001; postpartum infant serum: SARS-CoV-2+=5.50, SARS-CoV-2-=5.10, p = 0.003; Postpartum breast milk: SARS-COV-2+=3.25, SARS-COV-2-=2.61, p = 0.009). Significant positive correlations were found for anti-S IgG titres between paired maternal and infant samples at delivery and postpartum (Delivery: R = 0.91, p < 0.001; postpartum: R = 0.86, p < 0.001). CONCLUSIONS: Receipt of a SARS-CoV-2 vaccine and SARS-CoV-2 infection elicit strong IgG and IgA antibody responses in pregnant women with evidence of transplacental transfer to the fetus.
引用
- Korchinski I, Marquez C, McClymont E, et al. Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study. Vaccine. 2024. PMID: 38981741. doi:10.1016/j.vaccine.2024.07.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。